PALISADE BIO, INC. — Director's Dealing 2015

Jul 24, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2015-07-22

Reporting Person: JOHE KARL (Director, Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-07-22	Common Stock	M	1200000	$0.50	Acquired	1688947	Direct
2015-07-22	Common Stock	F	621016	$1.64	Disposed	1067931	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-07-22	Common Stock purchase option	$0.50	M	1200000	Disposed	2015-07-28	Common Stock (1200000)	Direct

Footnotes

F1: Represents 272,179 shares forfeited for tax witholding purposes and 348,837 shares withheld by the Issuer at the market price of $1.72 per share less an exercise price of $0.50 per share to fund the cashless exercise of 1,200,000 options. The total number of shares issued to Reporting Person pursuant to the cashless exercise of the options is 578,984.

F2: Represents option issued on July 28, 2005. The option was exercised on a cashless basis on 7/22/2015.